IP Library Granted Patent US 8,323,966
Granted Patent B2
US 8,323,966 · App. 12/823,739 · Granted Dec 4, 2012

Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes

Assignee: Geron Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,323,966
App. No.
12/823,739
Granted
Dec 4, 2012
Kind
B2
Abstract

The invention provides methods for depleting extraneous phenotypes from a mixed population of cells comprising the in vitro differentiated progeny of primate pluripotent stem cells. The invention also provides mixed cell populations enriched for a target cell phenotype where the mixed cell population comprises the differentiated in vitro progeny of primate embryonic stem cells.

Claims (8)

1. A method of reducing the number of extraneous phenotypic cells in a mixed population of cells comprising a) contacting the mixed population of cells with one or more ligands that specifically bind to the extraneous phenotypic cells; and b) separating the ligand bound extraneous phenotypic cells from the rest of the mixed population of cells thereby reducing the number of extraneous phenotypic cells from a mixed population of cells, wherein the mixed population of cells comprises the in vitro differentiated progeny of pPS cells including the extraneous phenotypic cells and wherein the ligand is an antibody that binds specifically to EpCAM and the mixed population of cells comprises a targeted phenotype and the targeted phenotype is an oligodendrocyte.

2. The method of claim 1 , wherein the extraneous phenotypic cell is an epithelial cell.

3. The method of claim 2 , wherein the epithelial cell expresses a cytokeratin.

4. The method of claim 1 , wherein the ligand is bound to a solid support.

5. The method of claim 4 , wherein the solid support is a bead.

6. The method of claim 5 , wherein the bead is a magnetic bead.

7. The method of claim 1 , wherein separating the ligand bound extraneous phenotypic cells from the rest of the mixed population of cells is performed by applying an external force to the mixed population of cells.

8. The method of claim 7 , wherein the external force is provided by a magnetic field.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2013
From: GERON CORPORATION
To: ASTERIAS BIOTHERAPEUTICS, INC.
Reel/Frame 031620/0567 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2010
From: LEBKOWSKI, JANE; PRIEST, CATHERINE; OKAMURA, ROSS
To: GERON CORPORATION
Reel/Frame 024617/0239 →
Continuity (2)
Provisional Application 61220418 · Jun 25, 2009
Related Publication 20100330670A1 · Dec 30, 2010